One Dose.
Healthy* Ears.
Happy Dog.

3-in-1 Convenient Single-Dose Treatment for Otitis Externa

Discover the benefits of MOMETAMAX ULTRA™. With a novel combination of active ingredients, this treatment provides the best of 3 worlds1:

  • Gentamicin—a broad-spectrum bactericidal antibiotic
  • Posaconazole—the most potent broad-spectrum antifungal
  • Mometasone furoate—a topical high potency corticosteroid with few systemic side effects

Novel Combination of 3 Active Ingredients


  • Rapidly kills susceptible bacteria, including Staphylococcus pseudintermedius and Pseudomonas aeruginosa2
  • Extensive track record of safe use and limited resistance in canine otitis externa3


  • Rapidly kills susceptible fungi, including Malassezia pachydermatis2
  • 40-100x more potent in vitro against M. pachydermatis than clotrmazole, miconazole, nystatin and terbinafine1,4,5

Mometasone furoate

  • A leading corticosteroid for otitis externa with a 10-year+ history
  • Reduces inflammation and resolves clinical signs (eg, redness, swelling, ulceration and discharge)

A Single-Dose, In-Clinic Treatment You Can Count On


  • Single-dose treatment
  • Novel combination of 3 active ingredients
  • Safety demonstrated in field studies, effective and convenient.

Improving Compliance

  • For veterinary professional use only
  • No administration struggles at home
  • Correct dosage ensured

Increasing Certainty

  • One in-clinic administration
  • Simple dosing
  • Provides up to 6 weeks efficacy

Designed With a Dog’s Ear
Anatomy in Mind

The 0.8-ml dose enters by gravity flow and coats the external ear
canal. No need to insert a syringe into the ear canal.

Veterinary Practitioner-Preferred Packaging

The multi-dose bottle of MOMETAMAX ULTRA contains sufficient product and syringes to treat 20 ears. The multi-dose bottle with syringes minimises inventory and shelf space. Add MOMETAMAX ULTRA to your portfolio of otitis externa medications.

References: 1. European Medicines Agency. Mometamax Ultra: EPAR – Product Information & Public Assessment Report. 2022. 2. Paterson S. J Small Anim Prac. 2016;57:668-678. 3. Bourely C, Cazeau G, Jarrige N, et al. Epidemiol Inf. 2019;147:1-10. 4. Peano A, Johnson E, Chiavassa E, et al. J Fungi. 2020;6:93. 5. Bourdeau P, Marchand AM, Etore F. Vet Dermatol. 2004;15:46.

*.L.Heuer; C. Wilhelm; O. Roy; W.Löhlein; O. Wolf; E. Zschiesche:
Clinical microbiology, safety, and efficacy of a single in-clinic dose
of gentamicin, posaconazole, and mometasone furoate in dogs
with otitis externa; Presented at WSAVA Congress; Lisbon, Portugal;
September 27-29, 2023.1.